Literature DB >> 28197391

High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer.

Cheng Sun1, Jing Xu2, Qiang Huang3, Mei Huang3, Hao Wen4, Chuanshan Zhang4, Jinyu Wang5, Jiaxi Song5, Meijuan Zheng6, Haoyu Sun5, Haiming Wei5, Weihua Xiao5, Rui Sun1, Zhigang Tian1.   

Abstract

Background and Aims: As the predominant lymphocyte subset in the liver, natural killer (NK) cells have been shown to be highly associated with the outcomes of patients with chronic hepatitis B virus infection (CHB) and hepatocellular carcinoma (HCC). Previously, we reported that NKG2A, a checkpoint candidate, mediates human and murine NK cell dysfunction in CHB. However, NK cell exhaustion and, particularly, the level of NKG2A expression within liver tumors have not been reported.
Methods: In this study, we analyzed NKG2A expression and the related dysfunction of NK cells located in intra- or peritumor regions of liver tissue samples from 207 HCC patients, in addition to analyzing disease outcomes.
Results: The expression of NKG2A in NK cells and the NKG2A ligand, HLA-E, in intratumor HCC tissues was observed to be increased. These NK cells, and particularly CD56dim NK cells, with higher NKG2A expression showed features of functional exhaustion and were associated with a poor prognosis. The increase in NKG2A expression might be induced by IL-10, which was present at a high level in the plasma of HCC patients. Blocking IL-10 could specifically inhibit NKG2A expression in NK cells. Conclusions: These findings indicate that NKG2A expression is influenced by factors from cancer nests and contributes to NK cell exhaustion, suggesting that NKG2A blockade has the potential to restore immunity against liver tumors by reversing NK cell exhaustion.

Entities:  

Keywords:  HLA-E; Hepatocellular carcinoma; NK cells; NKG2A; prognosis

Year:  2016        PMID: 28197391      PMCID: PMC5283631          DOI: 10.1080/2162402X.2016.1264562

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  42 in total

1.  CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.

Authors:  Kerstin Juelke; Monica Killig; Merlin Luetke-Eversloh; Eliana Parente; Joachim Gruen; Barbara Morandi; Guido Ferlazzo; Andreas Thiel; Isabela Schmitt-Knosalla; Chiara Romagnani
Journal:  Blood       Date:  2010-05-26       Impact factor: 22.113

2.  Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.

Authors:  Masahisa Jinushi; Tetsuo Takehara; Tomohide Tatsumi; Tatsuya Kanto; Takuya Miyagi; Takahiro Suzuki; Yoshiyuki Kanazawa; Naoki Hiramatsu; Norio Hayashi
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

3.  Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.

Authors:  Dongping Xu; Junliang Fu; Lei Jin; Hui Zhang; Chunbao Zhou; Zhengsheng Zou; Jing-Min Zhao; Bin Zhang; Ming Shi; Xilai Ding; Zirong Tang; Yang-Xin Fu; Fu-Sheng Wang
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

Authors:  Emilie Mamessier; Aude Sylvain; Marie-Laure Thibult; Gilles Houvenaeghel; Jocelyne Jacquemier; Rémy Castellano; Anthony Gonçalves; Pascale André; François Romagné; Gilles Thibault; Patrice Viens; Daniel Birnbaum; François Bertucci; Alessandro Moretta; Daniel Olive
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

Review 5.  Clinical and immunological significance of HLA-E in stem cell transplantation and cancer.

Authors:  L Wieten; N M Mahaweni; C E M Voorter; G M J Bos; M G J Tilanus
Journal:  Tissue Antigens       Date:  2014-12

6.  Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.

Authors:  Cheng-En Hu; Jun Gan; Rui-Dong Zhang; Yan-Ru Cheng; Guang-Jian Huang
Journal:  Scand J Gastroenterol       Date:  2010-09-07       Impact factor: 2.423

7.  Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.

Authors:  Estrella Mariel Levy; Michele Bianchini; Erika María Von Euw; Maria Marcela Barrio; Alicia Inés Bravo; David Furman; Enzo Domenichini; Carlos Macagno; Victor Pinsky; Cinzia Zucchini; Luisa Valvassori; José Mordoh
Journal:  Int J Oncol       Date:  2008-03       Impact factor: 5.650

8.  Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.

Authors:  Dimitra Peppa; Lorenzo Micco; Alia Javaid; Patrick T F Kennedy; Anna Schurich; Claire Dunn; Celeste Pallant; Gidon Ellis; Pooja Khanna; Geoffrey Dusheiko; Richard J Gilson; Mala K Maini
Journal:  PLoS Pathog       Date:  2010-12-16       Impact factor: 6.823

9.  TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.

Authors:  Cheng Sun; Binqing Fu; Yufeng Gao; Xiaofeng Liao; Rui Sun; Zhigang Tian; Haiming Wei
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823

Review 10.  Liver natural killer cells: subsets and roles in liver immunity.

Authors:  Hui Peng; Eddie Wisse; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2015-12-07       Impact factor: 11.530

View more
  79 in total

Review 1.  Next generation immune-checkpoints for cancer therapy.

Authors:  Chiara Donini; Lorenzo D'Ambrosio; Giovanni Grignani; Massimo Aglietta; Dario Sangiolo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

2.  Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment.

Authors:  Pulak Ranjan Nath; Dipasmita Pal-Nath; Ajeet Mandal; Margaret C Cam; Anthony L Schwartz; David D Roberts
Journal:  Cancer Immunol Res       Date:  2019-07-30       Impact factor: 11.151

Review 3.  Killers 2.0: NK cell therapies at the forefront of cancer control.

Authors:  Jonathan J Hodgins; Sarwat T Khan; Maria M Park; Rebecca C Auer; Michele Ardolino
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

4.  Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients.

Authors:  Jing Chen; Dan-Xue Zheng; Xing-Juan Yu; Hong-Wei Sun; Yi-Tuo Xu; Yao-Jun Zhang; Jing Xu
Journal:  Oncoimmunology       Date:  2019-08-15       Impact factor: 8.110

5.  Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.

Authors:  L Tao; S Wang; L Yang; L Jiang; J Li; X Wang
Journal:  Clin Exp Immunol       Date:  2020-05-17       Impact factor: 4.330

Review 6.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

7.  Impact of HLA Allele-KIR Pairs on HIV Clinical Outcome in South Africa.

Authors:  Masahiko Mori; Ellen Leitman; Bruce Walker; Thumbi Ndung'u; Mary Carrington; Philip Goulder
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

Review 8.  Genetic reprogramming for NK cell cancer immunotherapy with CRISPR/Cas9.

Authors:  Lukman O Afolabi; Adeleye O Adeshakin; Musbahu M Sani; Jiacheng Bi; Xiaochun Wan
Journal:  Immunology       Date:  2019-08-14       Impact factor: 7.397

Review 9.  Tumor-Infiltrating Natural Killer Cells.

Authors:  Beatriz Cózar; Marco Greppi; Sabrina Carpentier; Emilie Narni-Mancinelli; Laura Chiossone; Eric Vivier
Journal:  Cancer Discov       Date:  2020-12-04       Impact factor: 39.397

Review 10.  Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.